Beijing HuayiHuilang Medical Instrument Co., Ltd. to distribute Biohit Celiac Disease Quick Test in China
Biohit Oyj Press Release July 11, 2016 at 09:30 am local time (EEST)
Biohit Oyj and Beijing HuayiHuilang Medical Instrument Co., Ltd. have signed an agreement for the distribution of the Biohit Celiac Disease Quick Test in China.
Biohit Celiac Disease Quick Test allows the diagnosis of celiac disease from a fingertip blood sample within ten minutes. Celiac disease is a relatively common underdiagnosed autoimmune disease causing different types of stomach problems. In celiac patients the rye, wheat and barley protein (gluten) causes inflammation of the small intestine mucosa and damages the microvilli. This in turn interferes with the absorption of nutrients.
Celiac Quick Test measures all three celiac disease antibodies produced in the body. These are transglutaminase antibodies IgA/IgG/IgM. Negative results exclude celiac disease.
General Director Yisheng Fang, Beijing HuayiHuilang Medical Instrument Co., Ltd.: 'In China, celiac disease has so far received insufficient attention. Biohit’s sensitive and specific Celiac Disease Quick Test helps detect celiac disease patients among those with dyspeptic symptoms. The right diagnosis and a strict diet will bring significantly better life quality to these patients.”
CEO Semi Korpela, Biohit Oyj: ‘We are expanding our business operations in the large Chinese market by starting a cooperation with Beijing HuayiHuilang Medical Instrument Co., Ltd. In China there is an increasing need and expanding market for Celiac Disease Quick Test. We have started the registration in China required to obtain the marketing authorisation for the test.'
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com www.biohithealthcare.com/additional-information
Beijing HuayiHuilang Medical Instrument Co., Ltd. in brief
Beijing HuayiHuilang Medical Instrument Co., Ltd. (Huayi) is a professional medical device and IVD distribution company headquartered in Beijing, China. Huayi has a highly experienced sales team and well-established sales network in all regions of China. The company has cooperation with well-known clinical experts and doctors and a strong ability to promote sales. The customers of Huayi can be found all over China.